Call Number (LC) Title Results
RM666.D66 H56 1983 On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers : with particular reference to dopaminergic mechanisms in the central nervous system / 1
RM666.E38 E35 1996 Eicosanoids from biotechnology to therapeutic applications /
Eicosanoids : from biotechnology to therapeutic applications / 		2
RM666.E548 Proteinkinase inhibitors /
Zinc enzyme inhibitors : enzymes from microorganisms /
PARP inhibitors for cancer therapy / 		3
RM666.E548 D475 2009 Drug design of zinc-enzyme inhibitors functional, structural, and disease applications / 1
RM666.E548 L5 2009 Kinase inhibitor drugs 1
RM666.E548 P37 2002eb PARP as a therapeutic target / 1
RM666.E548 P65 2011 Poly (ADP-ribose) polymerase methods and protocols / 1
RM666.E548 P76 2011 Protein kinases as drug targets /
Protein kinases as drug targets 		2
RM666.E55 Stem cell therapy in Lysosomal storage diseases /
Therapeutic enzymes functions and clinical implications / 		2
RM666.E55 D57 2006eb Directory of therapeutic enzymes / 1
RM666.E55 E575 2010 Enzybiotics antibiotic enzymes as drugs and therapeutics / 1
RM666.E55 P476 1997 Pharmaceutical enzymes / 1
RM666.E58 E65 2003 Ephedra--is it worth the risk? / 1
RM666.E58 U55 1993i Domestic Chemical Diversion Control Act of 1993 P.L. 103-200, 107 Stat. 2333, December 17, 1993. 1
RM666.E78 W45 1988 Hydergine : pharmacologic and clinical facts / 1
RM666.E8 E74 1999 Ergot : the genus Claviceps / 1
RM666.E87 A44 1989 Allosteric modulation of amino acid receptors : therapeutic implications / 1
RM666.E87 E93 1992 Excitatory amino acid receptors : design of agonists and antagonists / 1
RM666.F47 L36 2011eb Figs : the genus Ficus / 1
RM666.F49 T84 2012 Twenty years of G-CSF clinical and nonclinical discoveries / 1